Clinical Trials Directory

Trials / Completed

CompletedNCT03873415

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

Assessment of Regional Gastrointestinal Absorption of BMS-986165 Using Pharmacoscintigraphic Evaluation in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate sites of gut absorption of BMS-986165 in males

Conditions

Interventions

TypeNameDescription
DRUGBMS-986165Oral administration

Timeline

Start date
2019-01-25
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2019-03-13
Last updated
2019-11-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03873415. Inclusion in this directory is not an endorsement.

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males (NCT03873415) · Clinical Trials Directory